Solésence Formally Concludes 10 Periods of Financials Cannot Be Relied Upon
SLSN sits 52% above its 52-week low of $0.613 on light trading volume (0.1× avg).
Summary
Solésence formally concluded that financial statements for ten periods from 2023 through Q1 2026 cannot be relied upon due to inventory costing errors, and will restate three annual reports and seven quarterly reports.
Key Events · Legal and Risk Events · SLSN
-
Non-Reliance on 10 Periods
On August 17, 2026, the Audit Committee, Board, and Executive Officers concluded that financial statements for December 31, 2023 through March 31, 2026 should no longer be relied upon.
-
Inventory Costing Errors
The historical process allocated labor and overhead using unsupported budget-based percentages, violating ASC 330. Inventories were overstated and cost of revenue misstated.
-
Affected Line Items
Errors impacted gross profit, operating income, net income, EPS, accumulated deficit, and total stockholders' equity across all affected periods.
-
Restatement Plan
The company expects to file amendments to 10-Ks for 2023, 2024, 2025 and 10-Qs for seven quarters in the coming weeks.
Analysis · SLSN · Industrial Applications And Services
On August 17, 2026, the Audit Committee, Board, and Executive Officers concluded that previously issued financial statements for ten periods—from December 31, 2023 through March 31, 2026—should no longer be relied upon due to inventory costing errors that violated ASC 330. The errors overstated inventories and misstated cost of revenue, gross profit, operating income, net income, EPS, accumulated deficit, and total stockholders' equity. The company will amend its 10-Ks for 2023, 2024, and 2025 and its 10-Qs for seven quarters in the coming weeks. This formal non-reliance conclusion goes beyond the 10-Q filed two days earlier, which disclosed the errors and material weakness but did not yet state that all these periods must be restated. Investors now face uncertainty about the accuracy of three years of reported results, and the restatement process itself may reveal further issues.
At the time of this filing, SLSN was trading at $0.93 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $65.7M. The 52-week trading range was $0.61 to $4.55. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.